Apella Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Buy |
9,170
+343
| +4% | +$64.4K | 0.05% | 175 |
|
|
2025
Q1 | $1.59M | Buy |
8,827
+756
| +9% | +$136K | 0.05% | 150 |
|
|
2024
Q4 | $1.43M | Buy |
8,071
+1
| +0% | +$178 | 0.06% | 140 |
|
|
2024
Q3 | $1.59M | Buy |
8,070
+501
| +7% | +$98.6K | 0.07% | 121 |
|
|
2024
Q2 | $1.27M | Buy |
7,569
+204
| +3% | +$34.3K | 0.06% | 134 |
|
|
2024
Q1 | $1.25M | Buy |
7,365
+104
| +1% | +$17.7K | 0.06% | 127 |
|
|
2023
Q4 | $1.17M | Sell |
7,261
-151
| -2% | -$24.4K | 0.07% | 125 |
|
|
2023
Q3 | $1.1M | Buy |
7,412
+315
| +4% | +$47K | 0.08% | 110 |
|
|
2023
Q2 | $956K | Buy |
+7,097
| New | +$956K | 0.07% | 119 |
|
|
2022
Q4 | $1.57M | Sell |
9,709
-428
| -4% | -$69.2K | 0.14% | 81 |
|
|
2022
Q3 | $1.36M | Buy |
10,137
+1,236
| +14% | +$166K | 0.16% | 82 |
|
|
2022
Q2 | $1.36M | Buy |
8,901
+325
| +4% | +$49.8K | 0.16% | 83 |
|
|
2022
Q1 | $1.39M | Buy |
8,576
+1,150
| +15% | +$186K | 0.2% | 76 |
|
|
2021
Q4 | $1.01M | Buy |
7,426
+343
| +5% | +$46.4K | 0.13% | 89 |
|
|
2021
Q3 | $764K | Buy |
7,083
+69
| +1% | +$7.44K | 0.11% | 103 |
|
|
2021
Q2 | $790K | Buy |
7,014
+869
| +14% | +$97.9K | 0.13% | 109 |
|
|
2021
Q1 | $665K | Buy |
6,145
+144
| +2% | +$15.6K | 0.21% | 75 |
|
|
2020
Q4 | $643K | Hold |
6,001
| – | – | 0.23% | 73 |
|
|
2020
Q3 | $526K | Sell |
6,001
-100
| -2% | -$8.77K | 0.21% | 78 |
|
|
2020
Q2 | $599K | Buy |
6,101
+209
| +4% | +$20.5K | 0.28% | 72 |
|
|
2020
Q1 | $449K | Buy |
+5,892
| New | +$449K | 0.26% | 70 |
|